SCHEMBL6429919

SCHEMBL6429919

CC(OC(=O)CC(=O)O)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP3 P08254 1/20 0.35
MMP9 P14780 1/20 0.35
MMP13 P45452 1/20 0.35
CYP2D6 P10635 1/20 0.35
LDHA P00338 1/20 0.33
SRR Q9GZT4 1/20 0.33
CTSK P43235 1/20 0.33
GRM1 Q13255 2/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
TSHR P16473 1/20 0.31
HMGCR P04035 1/20 0.31
CHRM1 P11229 1/20 0.31
TBXA2R P21731 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21273757 0.98 MMP1 (0.34) MMP1MMP2MMP3MMP9MMP13
SCHEMBL28727605 0.98 MMP1 (0.34) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6429917 0.89 CYP2D6 (0.38) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6441150 0.81 EGLN1 (0.42) MMP1MMP2MMP3MMP9MMP13
SCHEMBL7715916 0.80 LDHA (0.35) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6441153 0.79 LMNA (0.39) MMP1MMP2MMP3MMP9MMP13
SCHEMBL28727608 0.79 CA4 (0.35) CYP2D6GRM1CYP3A4CYP2C9CYP2C19
SCHEMBL21273758 0.79 CA4 (0.35) CYP2D6GRM1CYP3A4CYP2C9CYP2C19
Lithium Ion SCHEMBL28314313 0.79 CA4 (0.35) CYP2D6GRM1CYP3A4CYP2C9CYP2C19
SCHEMBL6442341 0.78 TSHR (0.50) TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119585252-A Bicyclic heteroaryl containing compounds as IKZF2 degrading agents 翁科皮亚治疗公司和SK生命科学实验室 2025-03-07 CN disclosed
WO-2025047490-A1 GAS SEPARATION MEMBRANE AND METHOD FOR PRODUCING GAS SEPARATION MEMBRANE 株式会社ダイセル 2025-03-06 WO disclosed
WO-2025028075-A1 TWO-PACK TYPE RESIN COMPOSITION 株式会社日本触媒 2025-02-06 WO disclosed
CN-119278199-A Kinesin KIF18A inhibitor and application thereof 上海湃隆生物科技有限公司 2025-01-07 CN disclosed
CN-116323837-B Polyurethane curing agent and application thereof 旭化成株式会社 2024-10-25 CN disclosed
CN-115916777-B ATX inhibitor and preparation method and application thereof 苏州爱科百发生物医药技术有限公司 2024-07-12 CN disclosed
CN-115335369-B GEM-disubstituted piperidine melanocortin subtype-2 receptor (MC 2R) antagonists and uses thereof 克林提克斯医药股份有限公司 2024-07-02 CN disclosed
CN-118271261-A Dicarbonyl compound containing cyclobutane segment and synthesis method thereof 中国科学技术大学 2024-07-02 CN disclosed
EP-3771720-B1 BLOCKED POLYISOCYANATE COMPOSITION, RESIN COMPOSITION, RESIN FILM AND LAMINATE ASAHI CHEMICAL IND (JP) 2024-05-01 EP disclosed
CN-111868051-B Aminopyrimidine derivatives as CTPS1 inhibitors 斯泰普制药股份公司 2024-04-09 CN disclosed
US-20010021718-A1 Procollagen C-proteinase inhibitors PFIZER INC. 2001-09-13 US disclosed
WO-2001047901-A1 OX(ADI)AZOLYL-HYDROXAMIC ACIDS USEFUL AS PROCOLLAGEN C-PROTEINASE INHIBITORS PFIZER LIMITED (GB) 2001-07-05 WO disclosed
EP-0565631-A1 ANTI-VIRAL COMPOUNDS. MERRELL DOW PHARMA (US) 1993-10-20 EP disclosed
US-5229243-A Addition polymer core, polyurethane or polythiourethane shell KAO CORPORATION (JP) 1993-07-20 US disclosed
EP-0254080-B1 MALONIC ACID DERIVATIVES AND METHODS FOR THEIR SYNTHESIS ENIRICERCHE S.p.A. (IT) 1993-03-17 EP disclosed
EP-0501673-A1 Encapsulated toner for heat pressure fixing Kao Corporation (JP) 1992-09-02 EP disclosed
WO-1992012123-A1 ANTI-VIRAL COMPOUNDS MERRELL DOW PHARMACEUTICALS INC. (US) 1992-07-23 WO disclosed
US-4914226-A Malonic acid derivatives and methods for their synthesis ENIRICERCHE S.P.A. (IT) 1990-04-03 US disclosed
EP-0254080-A2 Malonic acid derivatives and methods for their synthesis ENIRICERCHE S.p.A. (IT) 1988-01-27 EP disclosed
US-4596883-A Herbicidally active substituted diphenyl ethers PPG INDUSTRIES, INC. (US) 1986-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010021718-A1 Procollagen C-proteinase inhibitors MMP1, CTSL, PREP MMP1 1/4885MMP2 16/4885MMP3 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.